Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy
- PMID: 30916712
- DOI: 10.1001/jamacardio.2019.0546
Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy
Comment in
-
Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy-Reply.JAMA Cardiol. 2019 May 1;4(5):494-495. doi: 10.1001/jamacardio.2019.0556. JAMA Cardiol. 2019. PMID: 30916718 No abstract available.
Comment on
-
Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis.JAMA Cardiol. 2018 Nov 1;3(11):1050-1059. doi: 10.1001/jamacardio.2018.3551. JAMA Cardiol. 2018. PMID: 30383145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
